ALX Oncology Holdings Inc.
ALXO
$0.5214
-$0.0203-3.75%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.09M | 25.25M | 26.67M | 27.09M | 28.48M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 142.47M | 159.88M | 180.59M | 175.84M | 170.28M |
| Operating Income | -142.47M | -159.88M | -180.59M | -175.84M | -170.28M |
| Income Before Tax | -134.85M | -151.16M | -171.44M | -166.20M | -160.81M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -134.85 | -151.16 | -171.44 | -166.20 | -160.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -134.85M | -151.16M | -171.44M | -166.20M | -160.81M |
| EBIT | -142.47M | -159.88M | -180.59M | -175.84M | -170.28M |
| EBITDA | -141.15M | -158.57M | -179.29M | -174.78M | -169.22M |
| EPS Basic | -2.61 | -2.98 | -3.64 | -3.71 | -3.74 |
| Normalized Basic EPS | -1.63 | -1.86 | -2.27 | -2.32 | -2.34 |
| EPS Diluted | -2.61 | -2.98 | -3.64 | -3.71 | -3.74 |
| Normalized Diluted EPS | -1.63 | -1.86 | -2.27 | -2.32 | -2.34 |
| Average Basic Shares Outstanding | 207.45M | 203.64M | 192.10M | 181.14M | 171.88M |
| Average Diluted Shares Outstanding | 207.45M | 203.64M | 192.10M | 181.14M | 171.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |